(19)
(11) EP 1 807 118 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.04.2014 Bulletin 2014/17

(45) Mention of the grant of the patent:
12.03.2014 Bulletin 2014/11

(21) Application number: 05857726.3

(22) Date of filing: 29.09.2005
(51) International Patent Classification (IPC): 
A61K 31/568(2006.01)
A61K 31/56(2006.01)
A61P 43/00(2006.01)
A61K 31/569(2006.01)
C07J 1/00(2006.01)
A61K 49/00(2006.01)
(86) International application number:
PCT/US2005/035020
(87) International publication number:
WO 2006/110172 (19.10.2006 Gazette 2006/42)

(54)

STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS

STEROIDANALOGA SOWIE CHARAKTERISIERUNGS- UND BEHANDLUNGSVERFAHREN

ANALOGUES DE STEROIDES, PROCEDES DE CARACTERISATION ET TRAITEMENTS


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 29.09.2004 US 614869 P

(43) Date of publication of application:
18.07.2007 Bulletin 2007/29

(60) Divisional application:
12161344.2 / 2471536

(73) Proprietor: Harbor Therapeutics, Inc.
San Diego, CA 92122 (US)

(72) Inventors:
  • READING, Christopher
    San Diego, CA 92122 (US)
  • FRINCKE, James
    Del Mar, CA 92014 (US)
  • DOWDING, Charles
    San Diego, CA 92129 (US)

(74) Representative: Maiwald Patentanwalts GmbH 
Elisenhof Elisenstrasse 3
80335 München
80335 München (DE)


(56) References cited: : 
EP-A- 1 422 234
US-A1- 2003 060 425
US-A1- 2004 116 359
WO-A-01/30802
US-A1- 2003 083 231
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).